.OncoC4 is taking AcroImmune-- as well as its own in-house clinical production abilities-- under its...
.Amgen has discussed (PDF) the initial stage 3 records on its $400 million eczema drug, linking the ...
.Biogen as well as UCB's bet one's bottom dollar improving right into stage 3 astride an unsuccessfu...
.Italian biotech Aptadir Rehabs has actually launched with the assurance that its pipe of preclinica...
.Surge Lifestyle Sciences has satisfied its own target in a Duchenne muscular dystrophy (DMD) resear...
.After a handful of years in biotech, Mike Quigley, Ph.D., is actually going back to the pharma fold...
.Achilles Therapies has actually shreded its technique. The British biotech is quiting working on it...
.Aligos Therapies is actually declaring a midstage win in metabolic-dysfunction affiliated steatohep...
.Basilea Pharmaceutica's work developing new antifungals has actually received a notable boost from ...
.Having currently gathered up the U.S. civil rights to Capricor Therapeutics' late-stage Duchenne mu...